Targeting cancer metabolism in the era of precision oncology

ZE Stine, ZT Schug, JM Salvino, CV Dang - Nature reviews Drug …, 2022 - nature.com
One hundred years have passed since Warburg discovered alterations in cancer
metabolism, more than 70 years since Sidney Farber introduced anti-folates that …

The lactate and the lactate dehydrogenase in inflammatory diseases and major risk factors in COVID-19 patients

GS Gupta - Inflammation, 2022 - Springer
Lactate dehydrogenase (LDH) is a terminating enzyme in the metabolic pathway of
anaerobic glycolysis with end product of lactate from glucose. The lactate formation is crucial …

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma

M Pi, H Kuang, C Yue, Q Yang, A Wu, Y Li… - Drug Resistance …, 2022 - Elsevier
Cancer cell metabolism including aerobic glycolysis, amino acid and fatty acid metabolism,
has been extensively studied. Metabolic reprogramming is a major hallmark of cancer …

Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells

B Schroeder, T Vander Steen, I Espinoza… - Cell death & …, 2021 - nature.com
Inhibitors of the lipogenic enzyme fatty acid synthase (FASN) have attracted much attention
in the last decade as potential targeted cancer therapies. However, little is known about the …

ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY

D Liu, T Zhang, X Chen, B Zhang, Y Wang, M **e… - Cell Death & …, 2021 - nature.com
Metastasis is the predominant reason for high mortality of hepatocellular carcinoma (HCC)
patients. It is critical to explore the molecular mechanism underlying HCC metastasis. Here …

Metabolic reprogramming and macrophage polarization in granuloma formation

S Nakamizo, K Kabashima - International Immunology, 2024 - academic.oup.com
This review article delves into the complexities of granuloma formation, focusing on the
metabolic reprogramming within these immune structures, especially in tuberculosis and …

[HTML][HTML] Targeting cancer metabolic vulnerabilities for advanced therapeutic efficacy

TA Muluh, X Shu, Y Ying - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Cancer metabolism is how cancer cells utilize nutrients and energy to support their growth
and proliferation. Unlike normal cells, cancer cells have a unique metabolic profile that …

Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells

J Lee, S Jang, J Im, Y Han, S Kim, HA Jo… - Journal of Ovarian …, 2024 - Springer
Ovarian cancer is a leading cause of death among gynecologic tumors, often detected at
advanced stages. Metabolic reprogramming and increased lipid biosynthesis are key factors …

SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway

CY Kuo, YC Chang, MN Chien… - Endocrine-Related …, 2022 - erc.bioscientifica.com
Aberrant lipid metabolism provides bioenergetic, biosynthetic, and redox supplies to cancer
cells. Previous studies have reported differential lipid profiling in thyroid malignancies. Sterol …

Fatty acid synthase: a druggable driver of breast cancer brain metastasis

JA Menendez, R Lupu - Expert opinion on therapeutic targets, 2022 - Taylor & Francis
ABSTRACT Introduction Brain metastasis (BrM) is a key contributor to morbidity and
mortality in breast cancer patients, especially among high-risk epidermal growth factor …